Anti-Osteoporosis

Osteoporosis means porous bones. It is a silent disease, as bone loss initially occurs without any symptoms, and is usually diagnosed after bone fractures.

Osteoporosis is an outcome of an imbalance between the bone-making and bone-breaking processes in the body. It is common in both women and men, and the chances to get diagnosed with it increase with age.

Elderly women are more likely to suffer from it because the reduced oestrogen levels after menopause contribute to a rapid decline in bone mass. Patients with a history of a previous fracture have an 86% chance of getting a second fracture.

According to a study, 1 in 3 post-menopausal women will have an osteoporotic fracture in their lifetime. (Source: National Osteoporosis Foundation)

Osteoporosis management requires a balanced diet (Calcium, Vitamin D, Mineral enriched), exercise, along with adopting healthy habits like avoiding smoking and drinking alcohol.

It's a silent disease but we at Alkem heard and understood what the patients needed and took early initiatives:

• To raise social awareness about osteoporosis with the help of various patient educational media- patient education leaflets, posters, newspaper articles, and patient educational meets.
• For disease diagnosis and prevention - To pin down the disease at an early stage, Alkem organised various osteoporosis detection camps across India at rural, district, and metro city levels.
• For disease prevention - Alkem introduced various brands like the GEMCAL range (Calcium) and UPRISE range (Vitamin D3) to meet dietary insufficiency associated with Osteoporosis.

Alkem further introduced anti-resorptive therapies - GEMFOS (Residronate), GEMIDRO (Ibandronate), and GEMDRONIC (Zoledronic acid) injections–to prevent bone loss.

For patients with severe osteoporosis and at a high risk of fractures, Alkem entered the biosimilar segment and introduced GEMTIDE (Teriparatide) – an anabolic injection, for building new bones and Denu (Denosumab injection 60mg/ml) for persistent bone protection.

Today, with the help of strategic initiatives, Alkem is continuously innovating and working in the direction of osteoporosis – awareness, diagnosis, and management.